Telstar Promotes High-value Pharma Consultancy & Engineering at Asia Pharma Expo 2020

Telstar is an expert in the development of highly complex projects, from integrated process equipment to design, engineering and construction of complete turnkey pharmaceutical and biotech production facilities, critical installations, clean rooms, and R&D laboratories.

 

At Asia Pharma Expo, the company will be boosting its own consultancy service, providing regulatory compliance with GMP requirements in critical manufacturing processes set by different national and international health authorities. Telstar offers a fully comprehensive service encompassing the whole life cycle of the drug product. Telstar consultancy service covers engineering, preclinical, clinical and pharmacovigilance phases to ensuring that installations and equipment comply with all applicable GxP regulations (Good Engineering Practices, Good Clinical Practices, Good Laboratory Practices, Good Manufacturing Practices, Good Distribution Practices, and Good pharmacovigilance practices).

 

For the development of integrated critical and non-critical facilities and the construction of pharmaceutical and biotechnological plants, the company has a multidisciplinary team made up of subject matter experts in cGMP clean room installations and critical utilities, as well as being experienced in pharmaceutical production processes.

 

Bangladesh is one of the fastest growing economy in global markets. In fact, the pharmaceutical industry in the region is growing at more than 18% annual growth rate and emerging as global hub for the contract manufacturing for the pharmaceutical formulations. Telstar, which has been active over the past 16 years in the region, has its own office in Dhaka since 2014. The company is now represented in the Asia region by three specialized production plants and engineering centers in China, Bangladesh and India.